Direct Compression Lactose: Making the right choice

Transforming Pharmaceutical Manufacturing

Introduction

In the pharmaceutical industry, efficiency and quality are crucial. Direct compression has emerged as a revolutionary method in tablet manufacturing, offering streamlined processes and superior product quality. Armor Pharma is at the forefront with its specialized lactose excipients for direct compression: EXCIPRESS™ SD2L & GR150.

Part 1: Manufacturing Processes

Wet Granulation

Traditionally, wet granulation has been the go-to method for tablet production. This process involves mixing API(s) with excipients, adding a liquid binder to perform the granulation, and then drying the mixture. While effective, wet granulation is resource-intensive, requiring multiple steps, significant energy consumption, and extensive equipments.

• Complexity: Multiple stages including mixing, granulation, drying, and screening
• Resource-Intensive: High energy and water usage, leading to increased operational costs
• Time-Consuming: Longer production cycles due to wetting, granulation, drying and screening stages

Direct Compression

Direct compression simplifies tablet production by blending API(s) directly with excipients and compressing them into tablets. This method eliminates the need for granulation, offering several advantages:

• Reduced Costs: Fewer processing steps mean lower energy consumption and reduced labor costs. Direct compression requires less equipments, minimizing capital investment
• Efficiency: Streamlined production leads to faster cycle times, increasing throughput and reducing time-to-market
• Enhanced Product Quality: Consistent mixing and the use of flowable excipients result in uniform tablets with reliable weight and API content uniformity
• Alternative for APIs sensible to heat and/or humidity

Part 2: Advantages of Direct Compression Lactose

Flowability

Flowability is a critical factor in tablet manufacturing. Good flowability means it will be easy to fill the powder into the tablet machine specifically into the die of the tablet press. Therefore, the tablet weight will be constant and the API content will be uniform.

• Smooth Processing: Improved flow reduces machine downtime and enhances production efficiency
• Uniform Distribution: Ensures consistent tablet weight and API content uniformity reducing the risk of segregation

Compaction Properties

Compaction properties determine the mechanical strength of tablets. Armor Pharma’s lactose excipients offer exceptional compaction:

• Robust Tablets: Enhanced hardness and reduced friability ensure tablets withstand packaging and transportation
• Patient Safety: Durable tablets reduce breakage, ensuring accurate dosing and patient safety

Part 3: Focus on EXCIPRESS^TM GR150 and EXCIPRESS^TM SD2L

EXCIPRESS^TM GR150

EXCIPRESS^TM GR150 offers good compaction properties, making it ideal for formulations requiring robust tablets. It consists of agglomerates of primary lactose fine particles. It combines:

• Compaction: high compaction properties of fine lactose crystals
• Flowability: good flowability of coarse particles
• Good blending properties: due to its rough surface

EXCIPRESS^TM SD2L

EXCIPRESS^TM SD2L is renowned for its superior flowability and compaction properties. It consists of fine primary lactose particles bound in a matrix of amorphous lactose. It combines:

• Compaction: high compaction properties of fine lactose crystals and amorphous lactose
• Flowability: very good flowability of spherical particles. Its spherical shape facilitates efficient tablet production and ensures uniform distribution of API(s), reducing segregation and ensuring consistent tablet quality

Conclusion

Armor Pharma’s EXCIPRESS^TM GR150 and EXCIPRESS^TM SD2L lactose excipients are at the forefront of direct compression technology, offering unparalleled benefits in flowability and compaction. By choosing Armor Pharma, pharmaceutical manufacturers can achieve efficient, reliable, and high-quality tablet production, meeting the industry’s stringent standards.

Read more here

Source: Armor Pharma, website Direct Compression Lactose: Making the right choice – Armor Pharma

See also our CPhI Frankfurt overview article:

If you have any questions or need a sample by Amor Pharma, please feel free to contact us: